Evaporative Dry Eye Relief With MIEBO® (perfluorohexyloctane ophthalmic solution)

Leading expert Dr. Mila Ioussifova reveals how MIEBOⓇ (perfluorohexyloctane ophthalmic solution) may offer relief for dry eye disease (DED)—discover more about this treatment now! Evaporative DED, often linked to meibomian gland dysfunction, disrupts the tear film's protective lipid layer. DED is a chronic and challenging condition that affects millions. In this impactful episode of the Defocus Media Podcast, dry eye expert Dr. Mila Ioussifova shares her insights into the latest advances in diagnosing and treating evaporative DED. With a focus on MIEBO, Dr. Ioussifova explains how this FDA-approved Rx eye drop directly targets tear evaporation to treat the signs and symptoms of DED. Patients who have tried other treatment options, such as OTC artificial tears, and are still looking for relief may have success with MIEBO. Clinical studies showed that MIEBO offers significant improvement in both signs and symptoms at ~2 weeks, with continued improvement through ~8 weeks. Topics Covered: • The Nature of Evaporative DED: Dr. Ioussifova delves into how evaporative DED develops, emphasizing how meibomian gland dysfunction compromises tear stability, leading to chronic irritation and discomfort. • How MIEBO Provides Effective Relief: Dr. Ioussifova explains the unique benefits of MIEBO in stabilizing the lipid layer to combat tear evaporation, helping to interrupt the cycle of damage and discomfort common in DED. • Advanced Diagnostic Techniques: With meibography and other diagnostic tools, Dr. Ioussifova demonstrates the importance of assessing meibomian gland structure and function to provide tailored treatment options for dry eye patients. • Patient Education and Compliance: Dr. Ioussifova emphasizes the role of patient-centered care, helping patients identify lifestyle triggers and educating them on the importance of consistent treatment for managing symptoms effectively. INDICATION MIEBO® (perfluorohexyloctane ophthalmic solution) is indicated for the treatment of the signs and symptoms of dry eye disease. IMPORTANT SAFETY INFORMATION • MIEBO is contraindicated in patients with known hypersensitivity to perfluorohexyloctane • MIEBO should not be administered while wearing contact lenses. Contact lenses should be removed before use and for at least 30 minutes after administration of MIEBO • Instruct patients to instill one drop of MIEBO into each eye four times daily • The safety and efficacy in pediatric patients below the age of 18 have not been established • In pivotal trials, the most common ocular adverse reaction was blurred vision (1% to 3% of patients reported blurred vision and conjunctival redness) Please see full Prescribing Information for MIEBO at MIEBO-ECP.COM. -------------------------- You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. Let’s Connect! Defocus Media on Social Media: 👁️ Instagram:   / defocusmedia   👁️ Facebook:   / defocusmedia   👁️ LinkedIn:   / defocus-media   👁️ Twitter:   / defocusmedia   👀 Website: https://defocusmediagroup.com/ 👀 Want to stay up to date on the latest trends and hottest topics in eye care? 📧 Sign up for our newsletter! https://share.hsforms.com/1rhZdAHr_Ss... -------------------------- DISCLAIMER: All content in this video and description, including infor­ma­tion, opinions, con­tent, ref­er­ences, and links, is for infor­ma­tional pur­poses only. The Author does not pro­vide any med­ical advice on the site. Noth­ing con­tained in this video or its description is intended to estab­lish a physician-patient rela­tion­ship, to replace the ser­vices of a trained physi­cian or health care pro­fes­sional, or oth­er­wise to be a sub­sti­tute for pro­fes­sional med­ical advice, diag­no­sis, or treatment. You should con­sult a licensed physi­cian or appropriately credentialed health care worker in your com­mu­nity in all mat­ters relat­ing to your health. Also, some of the links in this post may be affiliate links, meaning, at no cost to you, I will earn a small commission if you click through and make a purchase. All non-licensed clips are used for fair use commentary, criticism, and educational purposes.